Search Results - "Keohan, Mary Lou"
-
1
IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting
Published in The Journal of pathology (01-07-2010)“…Solitary fibrous tumour (SFT) is a mesenchymal neoplasm composed of CD34-positive fibroblastic cells. The pathogenesis driving this neoplasm remains unclear,…”
Get full text
Journal Article -
2
Combined heart and lung transplantation for unresectable primary cardiac sarcoma
Published in The Journal of thoracic and cardiovascular surgery (01-12-2002)“…Objective: The prognosis for patients with primary cardiac sarcoma is poor. Median survival is less than 10 months, especially when complete surgical excision…”
Get full text
Journal Article -
3
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Published in Clinical cancer research (14-04-2022)“…Because the Hedgehog and Notch pathways are often overexpressed in mesenchymal malignancies, we evaluated the efficacy of concurrent inhibition of Notch and…”
Get full text
Journal Article -
4
-
5
IGF2 Overexpression in Solitary Fibrous Tumors is Independent of Anatomic Location and is Related to Loss of Imprinting
Published in The Journal of pathology (01-07-2010)“…Solitary Fibrous Tumor (SFT) is a mesenchymal neoplasm composed of CD34-positive fibroblastic cells. The pathogenesis driving this neoplasm remains unclear,…”
Get full text
Journal Article -
6
Phenotype of recovering lymphoid cell populations after marrow transplantation
Published in The Journal of experimental medicine (01-06-1985)“…Four patients who received bone marrow transplants were studied sequentially during the posttransplant period to define the pattern of recovering lymphoid cell…”
Get full text
Journal Article -
7
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma
Published in Investigational new drugs (01-01-1997)“…Bone and soft tissue sarcomas currently comprise 1% of adult malignancies and 15% of pediatric malignancies [1]. While doxorubicin and ifosfamide are active…”
Get full text
Journal Article